Fate Therapeutics Inc (NASDAQ:FATE)

20.90
Delayed Data
As of Dec 02
 +0.57 / +2.80%
Today’s Change
17.10
Today|||52-Week Range
66.56
-64.28%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 64.50, with a high estimate of 115.00 and a low estimate of 28.00. The median estimate represents a +208.61% increase from the last price of 20.90.

Analyst Recommendations

The current consensus among 22 polled investment analysts is to Buy stock in Fate Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.88
Sales
$19.5M
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.57%
 
 
 
 
 
 
Growthannually -43.95%
 
 
 
 
 
 

Sales

Growthquarterly 30.02%
 
 
 
 
 
 
Growthannually 24.10%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.